Terflavoxate
Alternative Names: ND-907; NS-907; REC-152053Latest Information Update: 16 Jul 1997
At a glance
- Originator Recordati
- Developer Dainippon Pharmaceutical; Nippon Shinyaku
- Class
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Urination disorders
Most Recent Events
- 16 Jul 1997 Discontinued-Clinical for Urination disorders in European Union (PO)
- 16 Jul 1997 Discontinued-II for Urination disorders in Japan (PO)
- 30 May 1996 Discontinued-II for Urinary incontinence in Germany (PO)